Register entry

Fareva

Data as of · How to read this entry

Registered sites
0
Active NDC listings
6
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

6

6 active NDC listings: 6 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 6.

Dosage formNDCs
injection6
RouteNDCs
Labeller name on the listingNDCs
fareva6
Catalogue

Marketed products

6
BrandGeneric nameForm / routeNDC
-BRENTUXIMAB VEDOTINinjection78848-003DRUG FOR FURTHER PROCESSING
-CETRORELIXinjection78848-005DRUG FOR FURTHER PROCESSING
-MYCOPHENOLATE MOFETILinjection78848-004DRUG FOR FURTHER PROCESSING
-TEMSIROLIMUSinjection78848-002DRUG FOR FURTHER PROCESSING
-TRASTUZUMABinjection78848-006DRUG FOR FURTHER PROCESSING
-TRASTUZUMABinjection78848-007DRUG FOR FURTHER PROCESSING
Compare

Other companies listing trastuzumab

Enquiry

Common questions

Is Fareva FDA approved?
Fareva holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Fareva make?
6 products are listed under Fareva in the openFDA NDC Directory, most often as injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.